A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers
NACompletedINTERVENTIONAL
Enrollment
110
Participants
Timeline
Start Date
September 30, 2004
Study Completion Date
June 30, 2008
Conditions
Hepatitis BNeoplasms
Interventions
DRUG
Lamivudine
Trial Locations (1)
Unknown
Queen Elizabeth Hospital, Hong Kong
All Listed Sponsors
lead
Hospital Authority, Hong Kong
OTHER_GOV
NCT00516945 - A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers | Biotech Hunter | Biotech Hunter